SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.79 |
| Enterprise Value ($M) | 0.37 |
| Book Value ($M) | 6.18 |
| Book Value / Share | 5.12 |
| Price / Book | 0.61 |
| NCAV ($M) | 3.15 |
| NCAV / Share | 2.61 |
| Price / NCAV | 1.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.11 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.44 |
| Current Ratio | 3.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.47 |
| Assets | 8.50 |
| Liabilities | 2.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 14.86 | |
| 13G | AdvisorShares Trust | 8.77 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,552 | 11,598 | 13.38 | |
| 2,230 | 15,019 | 14.85 | |
| 367 | 4,070 | 9.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INAB – IN8bio, Inc. | INDP – Indaptus Therapeutics, Inc. |
| INKT – MiNK Therapeutics, Inc. | INMB – INmune Bio, Inc. |
| INO – Inovio Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io